Cancer treatments should be licensed for all ages, oncologists say

Recent advances have resulted in highly effective “tissue-agnostic” drugs that treat cancers based on their molecular markers rather than their tissue of origin, but very few of these drugs are approved for use in children. In an opinion paper published in the journal Trends in Cancer, oncologists call for “ag(e)nostic” cancer treatments: drugs that are both tissue agnostic and approved for cancer patients of all ages.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup